New Delhi: Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of ₹1,387.48 crore for the quarter ended June 30, 2019.
The company had posted a profit of ₹1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE.
Total revenue from operations for the quarter under review stood at ₹8,374.36 crore. It was ₹7,224.17 crore for the same period a year ago.
"Pola Pharma lnc Japan became a step-down subsidiary of the company with effect from January 1, 20l9. Accordingly, the results for the quarter include results of Pola Pharma Inc, and hence are not comparable with quarter ended June 30, 2018," the company said.
Shares of Sun Pharmaceutical Industries were trading at ₹441 per scrip on BSE, up 4.53 per cent from the precious close.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.